Alteration of vascular thromboxane in rats with subtotal renal ablation.
To assess the roles of vascular prostaglandins in the hypertension of chronic renal failure, the release of prostacyclin and thromboxane (TX) from aorta was evaluated in male Sprague-Dawley rats, the renal mass of which was reduced by removing one kidney and two-thirds of the contralateral kidney ("5/6 nephrectomy"). Five-sixths nephrectomy was followed by significant rises in serum creatinine to 0.55 +/- 0.03 mg/dl and urea nitrogen to 42.9 +/- 3.8 mg/dl, with a concomitant rise in mean blood pressure from 121.6 +/- 1.6 mmHg to 155.3 +/- 8.4 mmHg. In 5/6 nephrectomized rats, the release of TX A2 from aorta, as measured by its stable metabolite TX B2, increased by 60% (p less than 0.01) and prostacyclin, as measured by its stable metabolite 6-keto-prostaglandin, F1 alpha (6-keto-PG F1 alpha) increased by 51% (p less than 0.05). The amounts of both TX B2 and 6-keto-PG F1 alpha released from aorta were closely related to the height of mean blood pressure. These results suggest that the enhanced vasoconstrictor TX production in the vascular walls may be relevant to hypertension in rats with subtotal renal ablation. The adaptive increase in prostacyclin production in the vascular walls may compensate for the elevation of blood pressure due to chronic renal failure in this animal model.
Ikeda
T
T
Department of Nephrology, Kanto-Teishin Hospital, Tokyo Japan.
Yuhara
M
M
Gomi
T
T
Ishimitsu
T
T
Uehara
Y
Y
D000818:Animals; D001011:Aorta / Q000378:metabolism*; D001794:Blood Pressure; D001835:Body Weight; D011464:Epoprostenol / Q000378:metabolism; D006977:Hypertension, Renal / Q000503:physiopathology; D007668:Kidney / Q000378:metabolism*; D008297:Male; D009392:Nephrectomy; D051381:Rats; D011919:Rats, Inbred Strains; D013931:Thromboxanes / Q000096:biosynthesis* / Q000097:blood*; D014662:Vasoconstrictor Agents / Q000097:blood / Q000378:metabolism*; D014667:Vasopressins / Q000096:biosynthesis* / Q000097:blood
D013931:Thromboxanes; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D011464:Epoprostenol